Physical frailty after liver transplantation

Am J Transplant. 2018 Aug;18(8):1986-1994. doi: 10.1111/ajt.14675. Epub 2018 Mar 13.

Abstract

Frailty is prevalent in liver transplant candidates, but little is known of what happens to frailty after liver transplantation. We analyzed data for 214 adult liver transplant recipients who had ≥1 frailty assessment using the Liver Frailty Index (LFI) at 3- (n = 178), 6- (n = 139), or 12- (n = 107) months posttransplant (higher values=more frail). "Frail" and "robust" were defined as LFI ≥4.5 and <3.2. Median pre-liver transplant LFI was 3.7, and was worse at 3 months (3.9; P = .02), similar at 6 months (3.7; P = .07), and improved at 12 months (3.4; P < .001). The percentage who were robust pre- and 3-, 6-, and 12-months posttransplant were 25%, 14%, 28%, and 37%; the percentage frail were 21%, 21%, 10%, and 7%. In univariable analysis, each 0.1 pretransplant LFI point more frail was associated with a decreased odds of being robust at 3- (odds ratio [OR] 0.75), 6- (OR 0.77), and 12-months (OR 0.90) posttransplant (P ≤ .001), which did not change substantially with multivariable adjustment. In conclusion, frailty worsens 3 months posttransplant and improves modestly by 12 months, but fewer than 2 of 5 patients achieve robustness. Pretransplant LFI was a potent predictor of posttransplant robustness. Aggressive interventions aimed at preventing frailty pretransplant are urgently needed to maximize physical health after liver transplantation.

Keywords: clinical research/practice; comorbidities; geriatrics; liver transplantation/hepatology; nutrition; patient characteristics; quality of life (QOL); rehabilitation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • End Stage Liver Disease / surgery*
  • Female
  • Follow-Up Studies
  • Frailty / diagnosis
  • Frailty / epidemiology*
  • Humans
  • Incidence
  • Liver Transplantation / methods*
  • Male
  • Middle Aged
  • Postoperative Complications*
  • Prognosis
  • Quality of Life*
  • Risk Factors
  • Severity of Illness Index*
  • United States / epidemiology